Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank29
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P29
Within normal range
vs 3Y Ago
-0.4x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$-86.10M+14.2%
2024$-100.41M+15.0%
2023$-118.11M-161.0%
2022$193.61M+485.3%
2021$-50.25M-60.6%
2020$-31.29M+32.5%
2019$-46.34M-104.6%
2018$-22.65M-